LynxCare

✨ From 17-18 October, we will be attending Frontiers Health 2024 in Berlin, one of the most renowned events in #DigitalHealth #Innovation.   We're grateful to have been selected to be part of this forum, engaging with global pioneers in #healthcare, and sharing our journey in leveraging precision medical data for research collaborations and enhancing patient outcomes.   Jeanne Kehren will be presenting LynxCare during the start-up and scale-up discovery session on 18 October at 3:30 PM. 📅   Looking forward to connecting! 💬   #FrontiersHealth #HealthTech #NLP #FH24

🩸 September marked #BloodCancerAwareness month! At LynxCare, we're harnessing the power of disease-specific #NLP to process complete EHRs, harmonize the data and bring accurate insights into the full patient pathway. 📊 By recognizing the immense value of untapped resources like narrative text in clinical reports (i.e., unstructured data), we're helping to drive breakthroughs in #leukemia, #lymphoma and #myeloma treatments.    Structured data alone only tells part of the story, often missing critical nuances. Watch our video 🎥 to explore how combining structured and unstructured data sources can offer a more precise and comprehensive understanding of blood cancer patients and populations.    #BloodCancerAwarenessMonth   🔬 Learn more about the hemato-oncology datasets in LynxCare's hospital network on, and request a feasibility study with just a few clicks: https://lnkd.in/eXjdEN47

We are at the #OHDSI UK Node 2024 Meeting! Join us from 15:00-16:00 as Dries Hens , M.D. presents our work on enhancing Hematologic #Oncology data capture leveraging our disease-specific #NLP pipelines, using the #OMOP CDM. 📊   Our poster is on display and available for download in the LynxCare Knowledge Center. Check it out! ➡️ https://lnkd.in/exUvQv5z   #Hematology #NLP #CLL #Myeloma #BloodCancerAwarenessMonth OHDSI (Observational Health Data Sciences & Informatics)

We'll be attending and exhibiting at #ISPOREurope 2024 in beautiful Barcelona from November 18-20! 🎉    Join us at booth 1126 to connect with our incredible team of clinical and data science experts. Dive into our latest real-world data research projects 📊, receive a demo of our innovative #NLP technology, and discover what makes our hospital network stand out 🏥. And we may still have a few surprises in store. Stay tuned! 👀   𝐀𝐭𝐭𝐞𝐧𝐝𝐢𝐧𝐠? 𝐋𝐞𝐭’𝐬 𝐦𝐚𝐤𝐞 𝐢𝐭 𝐡𝐚𝐩𝐩𝐞𝐧!  Visit our dedicated webpage to lock in a meeting at our booth ➡️ https://lnkd.in/eFyMwjWE, or reach out to join us for some tapas as we soak up the coastal vibes 🌊 of Barcelona. ➡️ https://lnkd.in/dn_FXMau

We're thrilled to announce that we'll be presenting at the #OHDSI UK Node 2024 Meeting this Friday!   M̳a̳r̳k̳ ̳y̳o̳u̳r̳ ̳c̳a̳l̳e̳n̳d̳a̳r̳s̳ 📰 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: Enhancing Hematologic #Oncology Data Capture in the #OMOP CDM: Methodological Advances and Challenges 🎤 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐫: Dries Hens , M.D. 📅 𝐃𝐚𝐭𝐞: 27 September ⏰ 𝐓𝐢𝐦𝐞: 15:00 - 16:00 📍 𝐕𝐞𝐧𝐮𝐞: Wellcome Trust, London   🔬 Our study focuses on the application of an #NLP pipeline within the #OMOP CDM to enhance the capture and characterization of key hematologic oncology variables. By tackling those challenging-to-capture variables, our work strives to bolster the robustness and completeness of hematologic oncology datasets, paving the way for more precise and comprehensive research on conditions like #CLL and multiple #myeloma.   But that's not all—our presentation will be recorded, and our poster will soon be available for download in the LynxCare Knowledge Center. 📥   #Hematology #BloodCancerAwarenessMonth   Abstract authors: Clara L. Oeste, Iege Bassez, Jana Van Canneyt, Alina Kramchaninova, Lucas Sterckx, Narges Farokhshad, Shahbaz Pervaiz, Geert Van Gorp, Dries Hens , M.D.

#ESMO2024 - you were great! It was a pleasure sharing our latest joint research projects in #oncology with so many of you.   🙏 A special thank you to Dr. Annelies Verbiest and Danielle Delombaerde for presenting our joint posters, along with all the contributing authors and hospitals ⬇️ who helped make these studies possible. Together, we are unlocking the power of precision medical data to gain deeper insights into both patient and population health.   Thank you to everyone who engaged with us in Barcelona —let's keep the conversations going as we continue to push the boundaries of oncology research together. 🚀   UZA, az groeninge, AZ Maria Middelares   👩🔬 A̳u̳t̳h̳o̳r̳s̳: Annelies Verbiest, Danielle Delombaerde, Clara L. Oeste, Philip Debruyne, Laura Tack, Lieselot Croes, PhD, Iege Bassez, Dries Hens , M.D., Constantijn Franssen, Hans Prenen, Johan De Sutter, Christof Vulsteke, Vincent Geldhof, Laura Deckx

#ESMO2024 – The Penultimate Day! We hope you had the opportunity to visit our poster sessions on Saturday. ❓ Missed it? No worries! 📚 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐂𝐞𝐧𝐭𝐞𝐫 to get a copy of our joint posters. If you have any questions or would like to discuss our findings, feel free to reach out - precision medical data at its finest! 𝐏𝐨𝐬𝐭𝐞𝐫𝐬 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝: 📄 Real-world usage and adverse events of immune checkpoint inhibitors (ICIs): A large-scale, automated, GDPR-compliant analysis of hospital records. ➡️ D̳o̳w̳n̳l̳o̳a̳d̳ ̳h̳e̳r̳e̳: https://lnkd.in/eXf6Pjde 📄 Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: Evidence from a Belgian real-world multicenter study ➡️ D̳o̳w̳n̳l̳o̳a̳d̳ ̳h̳e̳r̳e̳: https://lnkd.in/eH3D9sN2 AZ Maria Middelares, az groeninge, UZA #ImmunoOncology #Oncology

#ESMO24 - We are here!   📅 𝐌𝐚𝐫𝐤 𝐲𝐨𝐮𝐫 𝐜𝐚𝐥𝐞𝐧𝐝𝐚𝐫𝐬: D̳a̳t̳e̳: Saturday, 14 September T̳i̳m̳e̳: 12:00 - 13:00 P̳o̳s̳t̳e̳r̳s̳: 🔹 Real-world usage and 𝐚𝐝𝐯𝐞𝐫𝐬𝐞 𝐞𝐯𝐞𝐧𝐭𝐬 of 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 (ICIs): A large-scale, automated, GDPR-compliant analysis of hospital records (1056P) 🔹 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐢𝐞𝐬 in cancer patients treated with 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬: Evidence from a Belgian real-world multicenter study (1048P) P̳r̳e̳s̳e̳n̳t̳e̳r̳s̳: Dr. Annelies Verbiest (UZA), Danielle Delombaerde (AZ Maria Middelares)   And say 'hi' 👋 to our lynxes Dries Hens , M.D., Clara L. Oeste, and Iege Bassez! #ImmunoOncology #Oncology #RealWorldEvidence #RWE #RealWorldData #RWD

Two joint abstracts have been accepted for poster presentation at #ESMO2024! 🌟 The abstracts are now available, and we couldn’t be more proud to share them: 🔹 Real-world usage and 𝐚𝐝𝐯𝐞𝐫𝐬𝐞 𝐞𝐯𝐞𝐧𝐭𝐬 of 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 (ICIs): A large-scale, automated, GDPR-compliant analysis of hospital records (1056P) P̳r̳e̳s̳e̳n̳t̳e̳d̳ ̳b̳y̳ Annelies Verbiest, UZA 📅 Saturday, 14 September, 12.00-13.00 🔹 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐢𝐞𝐬 in cancer patients treated with 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬: Evidence from a Belgian real-world multicenter study (1048P) P̳r̳e̳s̳e̳n̳t̳e̳d̳ ̳b̳y̳ Danielle Delombaerde, AZ Maria Middelares 📅 Saturday, 14 September, 12.00-13.00   In these studies, we've analyzed full EHRs of over 1,500 ICI-treated patients leveraging our #NLP-#AI technology, revealing a deeper and more precise understanding of both adverse events and clinical outcomes.   Read the abstracts here: https://lnkd.in/ecgZ_9SY   Dries Hens , M.D., our Chief Medical Officer & co-founder, Clara L. Oeste, Senior Medical Writer, and Iege Bassez, Product Owner & Analytics Engineer, will be attending and are eager to tell you more about our latest research projects in #oncology and explore how we can create new opportunities for research collaborations across Europe. ✨ This achievement wouldn’t have been possible without the contributions from our partners and dedicated LynxCare team!   A̳u̳t̳h̳o̳r̳s̳: Annelies Verbiest, Danielle Delombaerde, Clara L. Oeste, Philip Debruyne, Laura Tack, Lieselot Croes, PhD, Iege Bassez, Dries Hens , M.D., Constantijn Franssen, Hans Prenen, Johan De Sutter, Christof Vulsteke, Vincent Geldhof, Laura Deckx UZA, AZ Maria Middelares, az groeninge #ImmunoOncology

✨ Exciting times ahead! In less than 4 weeks, we’ll be attending #ESMO2024 in Barcelona.   While the venue impresses with its cutting-edge sustainable design —featuring one of the largest rooftop photovoltaic plants in Europe — our two joint posters are ready to shine just as bright! 🌞   We’re thrilled to be presenting our multi-center real-world studies that delve into the 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐢𝐦𝐦𝐮𝐧𝐞 𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 (ICIs) in treating real-world #cancer patients.   W̳i̳l̳l̳ ̳y̳o̳u̳ ̳b̳e̳ ̳t̳h̳e̳r̳e̳?̳ 𝐋𝐞𝐭’𝐬 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 if you’re attending! You can schedule a meeting through our online agenda, or simply reach out to grab a coffee ☕ in Barcelona. ➡️ https://lnkd.in/eU5xtkMb   Stay tuned for the reveal of our posters - just a little more patience needed!   #ImmunoOncology #RealWorldData #RealWorldEvidence